MedPath

Power-Up: An Effectiveness Trial of the Diabetes Prevention Program

Not Applicable
Completed
Conditions
Type 2 Diabetes
Pre-Diabetes
Interventions
Other: Men-Tailored DPP (Power-Up)
Registration Number
NCT04104243
Lead Sponsor
Albert Einstein College of Medicine
Brief Summary

The goal of this study is to address the risk of diabetes among men by creating a Diabetes Prevention Program (DPP) tailored to men.

Detailed Description

The rising epidemic of type 2 diabetes is a major cause of disability and death that disproportionately affects men. Compared to women, men have much worse health and higher death rates for several chronic conditions, including diabetes. The National Diabetes Prevention Program (NDPP) has been shown to help decrease the chances of developing type 2 diabetes. The NDPP has shown the value of lifestyle change for weight loss and diabetes prevention. The Power-Up study is being done because although the evidence points to the effectiveness of the Diabetes Prevention Program (DPP), men are less likely to be engaged or participate in DPP.

The Power-up study was designed to see whether a DPP tailored for men can help improve engagement, participation, and results for men. Participants will be randomized to either undergo the Power-Up or standard NDPP classes. An assessment of whether a DPP created for men will increase participation in the program and decrease the risk for diabetes as compared to the standard NDPP. Power-Up is designed to Aim 1) Assess the effect of Power-Up vs. standard care NDPP on percent weight loss among men at risk for diabetes; Aim 2) Compare engagement of minority men at risk for diabetes in Power-Up vs. standard care NDPP; and Aim 3) Evaluate the Reach, Effectiveness, Adoption, Implementation, and Costs of Power-Up using the RE-AIM framework. The Power-Up intervention is tailored to the needs and preferences of men and uses: a) men coaches; b) men-only groups; c) messaging tailored to be appreciated and motivational to men; d) adapted content that highlights issues relevant to men.

There are 22-28 classes over the course of 12 months for both Power-Up and standard NDPP. The classes are split into two phases which are called the core and the maintenance phases. The core phase of the program will consist of at least 16 classes over the first 6 months. After the core, participants will attend maintenance classes over the next 6 months. Participants will be asked over the course of the 12 months to complete surveys at three different times before, during, and after completing the classes.

The hypothesis is that men randomized to Power-Up will achieve significantly greater weight loss (% weight loss from baseline) at 16 weeks and 1 year than men randomized to the standard care, mixed-gender NDPP group (Aim 1). Evaluation of engagement and retention for Aim 2 is based on attendance records for Power-Up and NDPP sessions electronically collected by trained coaches and monitored by study staff. The standards will be followed for NDPP evaluation where engagement is defined as equal or greater than 4 core sessions attended and retention is defined as equal or greater than 9 sessions attended. There will be a collection of quantitative and qualitative data that will be rigorously evaluated: the reach of our recruitment, broader patient-important indicators of effectiveness, adoption at the practice level, and implementation of the intervention (Aim 3).

Enrollment consists of 300 participants through our health system partners. Men will be randomized 1:1 to either the Power-Up intervention arm or referred to the standard NDPP at their clinic site. Consistent with current Centers for Disease Control and Prevention (CDC) standards and current NDPP practices of our health system partners, telephone make-up sessions will be offered by coaches in both conditions to men who miss in-person sessions.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
301
Inclusion Criteria
  • At least 18 years old
  • Most recent HbA1c: 5.7%-6.4% (within last year) or Diabetes Risk Score >= 5
  • Most recent BMI ≥ 25 (within last 6 months)
  • Access to a device that can join sessions virtually either through a virtual conferencing application
  • Have valid address and telephone contact information
  • Have no plans to change their health system/primary care provider or move from their current, NYC area, address in the next year
Exclusion Criteria
  • Not physically able or willing to attend virtual, group-based sessions
  • Unable to provide informed consent by telephone
  • Unable or unwilling to complete baseline telephone surveys or follow-up surveys in English or Spanish

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Power-UpMen-Tailored DPP (Power-Up)Participants randomized to this arm will undergo 16 classes tailored for men, that discuss food choices, physical activity, and managing stress over 6 months, which are called the core, and 6 classes over the following 6 months, which is called the maintenance phase.
Primary Outcome Measures
NameTimeMethod
Percent Weight Loss through 16 sessionsUp to 6 months, after the delivery of the 16th session (end of the core phase)

Compare Percent Weight Loss through 16 sessions.

Percent Weight Loss through the 12 month trial12 Months (At end of maintenance phase)

Compare Percent Weight Loss through the 12 month trial.

Secondary Outcome Measures
NameTimeMethod
Comparison of Engagement and Retention of Men vs Standard Diabetes Prevention Program12 Months (At end of the maintenance phase)

Compare engagement of men at risk for diabetes in Power-Up vs. Standard DPP. The number of sessions attended. Engagement rates are characterized as attending at least 4 sessions. Retention is defined as attending 9 or more sessions. We expect men randomized to the Power-Up sessions will have greater engagement and retention rates than men randomized to standard care and referred to mixed-gender NDPP classes.

Trial Locations

Locations (1)

Albert Einstein College of Medicine

🇺🇸

Bronx, New York, United States

© Copyright 2025. All Rights Reserved by MedPath